Little Helpers React to Ultrasound
September 20, 2018 | FAUEstimated reading time: 2 minutes

Nanoparticles are to be used like transporters to deliver medication in a targeted manner exactly where it is required in the human body? All over the world, scientists are working on so-called drug delivery technologies, as are researchers at FAU. The idea is that nanoparticles should react to ultrasound frequencies and release the active ingredients to precisely the right target areas only. The German Research Foundation (DFG) has now granted funding of a total of 600,000 euros for the next three years for this interdisciplinary research project.
Drug delivery technology provides great advantages for patients, especially for cancer patients. If medication is taken orally or injected into a blood vessel, it is distributed across the entire body. In the case of chemotherapy, this can lead to damage in areas of the body that are not affected by the cancer. Releasing medication in target areas of the body would prevent such unpleasant damage. The most suitable carriers for the drugs are extremely small particles in the nanometre range that can penetrate deep into the tissue requiring treatment via tiny blood vessels.
Two Areas of Research
‘In our project, we use so-called sonosensitive nanoparticles made of polymers that react to ultrasound waves, which are injected into the bloodstream’, says Prof. Dr. Helmut Ermert, former Chair of High Frequency Engineering at Ruhr-University Bochum and visiting professor at the Chair of Sensor Technology at FAU since his retirement. These particles carry the pharmaceutical ingredients that are not yet active in this state. Using bundled ultrasound waves, these particles can release the medication they carry at precisely the location where it is needed, explains Ermert.
The researcher is working with PD Dr. Stefan Rupitsch at the Chair of Sensor Technology at the Faculty of Engineering at FAU and Prof. Dr. Geoffrey Lee, Chair of Pharmaceutical Technology at the Faculty of Sciences at FAU on the interdisciplinary and inter-departmental project. On the one hand, this project involves developing both an ultrasound system that allows the active ingredients to be released only in those areas where it is needed and a sensor system that monitors and maps this release in the body. On the other, the researchers are seeking to produce the nanoparticles that will function both as carriers and also react to ultrasound waves and release the active ingredient. The German Research Foundation (DFG) is providing around 610,000 euros of funding for the project until autumn 2021.
Precursor Projects Use Magnets
The researchers at FAU are complementing other projects that have been running for several years at the Chairs of Sensor Technology and Pharmaceutical Technology in cooperation with the Professorship for Nanomedicine at the Faculty of Medicine under the leadership of Prof. Dr. Christoph Alexiou. In these cases, magnetic nanoparticles, which are injected into a blood vessel near the tumour, are used as carriers for active ingredients. Using a strong magnet outside the body, the transported medication can take effect thanks to the prolonged retention times and concentration of the nanoparticles. However, nanoparticles controlled by ultrasound have an advantage, says Prof. Emert, as focused ultrasound enables regions deeper within the body to be reached and treatment can be limited to smaller areas of tissue.
Testimonial
"We’re proud to call I-Connect007 a trusted partner. Their innovative approach and industry insight made our podcast collaboration a success by connecting us with the right audience and delivering real results."
Julia McCaffrey - NCAB GroupSuggested Items
AI-Powered Wearables Transform How Consumers Interact with Everyday Technology
09/15/2025 | PR NewswireThe global demand for AI-driven, touchless wearable technologies is accelerating as consumers seek more natural, seamless and intuitive ways to interact with their devices. Traditional touch screens and voice assistants, while effective, are increasingly viewed as limiting in a world where multitasking, mobility and efficiency are key. As industries from consumer electronics to augmented reality and enterprise computing embrace the possibilities of gesture-based control, the market for neural interfaces is rapidly expanding
Hanwha Aerospace to Collaborate with BAE Systems on Advanced Anti-jamming GPS for Guided Missiles
09/15/2025 | HanwhaHanwha Aerospace has signed a contract with BAE Systems to integrate next-generation, anti-jamming Global Positioning System (GPS) technology into Hanwha Aerospace’s Deep Strike Capability precision-guided weapon system.
United Electronics Corporation Unveils Revolutionary CIMS Galaxy 30 Automated Optical Inspection System
09/11/2025 | United Electronics CorporationUnited Electronics Corporation (UEC) today announced the launch of its new groundbreaking CIMS Galaxy 30 Automated Optical Inspection (AOI) machine, setting a new industry standard for precision electronics manufacturing quality control. The Galaxy 30, developed and manufactured by CIMS, represents a significant leap forward in inspection technology, delivering exceptional speed improvements and introducing cutting-edge artificial intelligence capabilities.
Intel Announces Key Leadership Appointments to Accelerate Innovation and Strengthen Execution
09/09/2025 | Intel CorporationIntel Corporation today announced a series of senior leadership appointments that support the company’s strategy to strengthen its core product business, build a trusted foundry, and foster a culture of engineering across the business.
DARPA, State of New Mexico Establish Framework to Advance Quantum Computing
09/08/2025 | DARPAAs part of the Quantum Benchmarking Initiative (QBI), DARPA signed an agreement with the State of New Mexico’s Economic Development Department to create the Quantum Frontier Project.